Skip to content
About
Board
Management
Business Development
Work at IDT
Pharmaceutical Services
Regulatory Compliance
Tax Incentives
Sterile Facility
Medicinal Cannabis
Investors
ASX Announcements
Share Price
Corporate Governance
Investor Presentations
Annual Reports
News
Contact
Jane Ryan
Home
»
Board and Management
About
Board
Management
Business Development
Work at IDT
Board
Alan Fisher
Chair
Hugh Burrill
Chair Audit & Risk Committee
Michael Kotsanis
Director
Management
Dr David Sparling
Chief Executive Officer
Ancila Desai
Chief Financial Officer, Company Secretary
Paul McDonald
Head of Quality and Development
